Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.13 - $0.38 $2,306 - $6,743
17,745 Added 24.08%
91,447 $11,000
Q2 2023

Aug 14, 2023

SELL
$0.88 - $1.22 $51,378 - $71,229
-58,385 Reduced 44.2%
73,702 $72,000
Q1 2023

May 15, 2023

SELL
$0.91 - $1.82 $133,073 - $266,147
-146,235 Reduced 52.54%
132,087 $151,000
Q4 2022

Feb 14, 2023

BUY
$0.78 - $1.68 $48,009 - $103,404
61,550 Added 28.39%
278,322 $223,000
Q3 2022

Nov 14, 2022

SELL
$1.59 - $2.74 $283,495 - $488,539
-178,299 Reduced 45.13%
216,772 $340,000
Q2 2022

Aug 15, 2022

BUY
$1.56 - $3.25 $595,478 - $1.24 Million
381,717 Added 2858.45%
395,071 $707,000
Q1 2022

May 16, 2022

SELL
$1.61 - $5.2 $722,162 - $2.33 Million
-448,548 Reduced 97.11%
13,354 $42,000
Q4 2021

Feb 14, 2022

BUY
$2.87 - $6.29 $87,204 - $191,121
30,385 Added 7.04%
461,902 $1.4 Million
Q3 2021

Nov 15, 2021

SELL
$4.91 - $9.07 $113,155 - $209,027
-23,046 Reduced 5.07%
431,517 $2.69 Million
Q2 2021

Aug 16, 2021

BUY
$7.82 - $13.8 $2.17 Million - $3.84 Million
277,999 Added 157.45%
454,563 $3.87 Million
Q1 2021

May 17, 2021

SELL
$13.0 - $19.34 $3.84 Million - $5.72 Million
-295,525 Reduced 62.6%
176,564 $2.71 Million
Q4 2020

Feb 16, 2021

SELL
$13.03 - $17.09 $1.3 Million - $1.7 Million
-99,544 Reduced 17.41%
472,089 $7.62 Million
Q3 2020

Nov 16, 2020

BUY
$12.67 - $23.19 $6.06 Million - $11.1 Million
478,176 Added 511.65%
571,633 $7.99 Million
Q2 2020

Aug 14, 2020

SELL
$12.52 - $23.45 $485,099 - $908,593
-38,746 Reduced 29.31%
93,457 $1.99 Million
Q1 2020

May 14, 2020

BUY
$11.4 - $27.28 $1.51 Million - $3.61 Million
132,203 New
132,203 $2.19 Million
Q4 2019

Feb 14, 2020

SELL
$9.68 - $18.67 $558,042 - $1.08 Million
-57,649 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$10.42 - $22.04 $329,115 - $696,133
31,585 Added 121.18%
57,649 $705,000
Q2 2019

Aug 15, 2019

SELL
$17.07 - $18.84 $7,015 - $7,743
-411 Reduced 1.55%
26,064 $491,000
Q2 2019

Aug 14, 2019

BUY
$17.07 - $18.84 $451,928 - $498,789
26,475 New
26,475 $115,000

Others Institutions Holding BCEL

About Atreca, Inc.


  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.